AgomAb Therapeutics NV American Depositary Shares (AGMB) — Tangible Net Worth Ratio
AgomAb Therapeutics NV American Depositary Shares (AGMB) has a Tangible Net Worth Ratio of 86.3% as of March 2026. This metric is calculated by deducting intangible assets ($20.11 Million) from net assets ($146.93 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See AGMB current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
AgomAb Therapeutics NV American Depositary Shares Tangible Net Worth Ratio (2021–2025)
This chart shows how AgomAb Therapeutics NV American Depositary Shares's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 86.3%, reflecting net assets of $146.93 Million with intangible assets of $20.11 Million USD. See AgomAb Therapeutics NV American Deposita defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for AgomAb Therapeutics NV American Depositary Shares (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for AgomAb Therapeutics NV American Depositary Shares from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see AGMB market cap.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 84.6% | $130.90 Million | $20.11 Million | $153.71 Million | ▼ -4.7 pp |
| 2024 | 89.3% | $188.08 Million | $20.11 Million | $206.36 Million | ▲ +2.6 pp |
| 2023 | 86.7% | $151.44 Million | $20.11 Million | $171.26 Million | ▲ +17.1 pp |
| 2022 | 69.6% | $66.25 Million | $20.11 Million | $101.00 Million | ▲ +17.1 pp |
| 2021 | 52.5% | $42.36 Million | $20.11 Million | $84.00 Million | — |